Showing results (331-340 of 369) with videos related to
Sort By:
Pageof 37
Clinical and Translational Medicine|July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biologySamuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.BMJ Open|May 4, 2026
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort studyEmily I Holthuis, Vicky L M N Soomers, Meena Rafiq, et al.The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.Frontiers in Oncology|June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case seriesJessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.Cancer|May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomasSeth M Pollack, Qianchuan He, Jennifer H Yearley, et al.European Journal of Cancer (Oxford, England : 1990)|August 20, 2023
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label studyHans Gelderblom, Robin L Jones, Jean-Yves Blay, et al.Analytical Chemistry|December 10, 2016
International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence VariantAlexandra S Whale, Alison S Devonshire, George Karlin-Neumann, et al.Cancer Medicine|March 13, 2021
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literatureAnna M Frezza, Vinod Ravi, Salvatore Lo Vullo, et al.European Journal of Cancer (Oxford, England : 1990)|October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgeryEvan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.Pageof 37